Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-07

Clinical Trial Update: Maresin-1 and Resolvin-D1 Levels and Disease Activity in Ulcerative Colitis

View source ↗

Summary

A clinical trial evaluating Maresin-1 and Resolvin-D1 levels and disease activity in Ulcerative Colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Maresin-1 (maresin-1)
  • Resolvin-D1 (resolvin-d1)

Snippet

Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | Conditions: Disease Activity, Remission of Ulcerative Colitis | Status: COMPLETED